Category | Insight journal

Asset purchase deal trends among life sciences companies

Posted on 19 September 2014

An asset purchase agreement is an agreement between a buyer and a seller that finalizes terms and conditions related to the purchase and sale of life sciences company’s assets.

Tags: , , ,

Isis Pharmaceuticals: Partnering activity 2009-2014

Posted on 15 September 2014

Isis Pharmaceuticals, a leader in antisense drug discovery, has emerged as a top 50 big biotech company with its business strategy.

Tags: , ,

Akorn to bid for an acquisition of UCB’s subsidiary

Posted on 15 September 2014

Akorn targets UCB‘s subsidiary for acquisition for tax inversion. 

Tags: , ,

Current Agreements Deal Analysis Update : September 2014

Posted on 08 September 2014

This month we provide you with an overview of life science deal making activity, covering partnering, M&A and financing in August 2014.

Tags: , , , ,

Jazz Pharmaceuticals – A new entry into the top 50 biotech of 2014

Posted on 08 September 2014

Headquartered in Dublin, Ireland Jazz Pharmaceuticals is a specialty biopharmaceuticals company that has undergone significant growth in recent years. Jazz Pharmaceuticals is focused upon delivering products for cataplexy, narcolepsy, oncology/leukemia, chronic pain and non-opioid schizophrenia.  

Tags: , , ,

Orphan diseases partnering: A lucrative step for drug makers

Posted on 02 September 2014

By Shamini Thiagarajan Increased collaborations, big pharma involvements, venture capital investments, and medical/technological breakthroughs are together changing the landscape of research and development in orphan diseases.

Tags: , ,

Isis Pharmaceuticals: So many partnerships, so little time

Posted on 02 September 2014

Isis Pharmaceuticals is an antisense drug discovery technology company developing therapies for a number of serious diseases.

Tags: , , ,

Pharma and biotech clinical stage partnering – recent trends 2009 to 2014

Posted on 02 September 2014

Partnering trends for the top pharma and biotech companies reviewed with over 2,000 deals analyzed – including summary biopharma deal financials

Tags: , , , , ,

Preclinical stage partnering – recent trends 2009 to 2014

Posted on 02 September 2014

Recent trends in preclinical partnering for the top pharma and biotech companies reviewed, over 2,000 deals analyzed – including summary of biopharma deal financials

Tags: , , , ,

Discovery stage in pharma and biotech partnering – Trends from 2009 to 2014

Posted on 02 September 2014

Numerous pharma and biotech partnering deals have been signed at the discovery stage over the past few years; discovery stage deals remain the most popular stage at which deals are announced.

Tags: , , ,

cpbannerad300x150new1gif
bpa14banner300x150jpg
currentpartneringpharma-bio300x150gif
RSS Feed Linked In Twitter

Latest Tweets

cpbannerad300x150new2gif
strategicalliances082114jpg
epicbanner1landscapejune11jpg